
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL_L | 1,357 | 59.3% | 1.93 | 5,165 | 57.5% |
| AL_R | 831 | 36.3% | 2.17 | 3,737 | 41.6% |
| EB | 39 | 1.7% | 0.07 | 41 | 0.5% |
| CRE_L | 25 | 1.1% | -0.40 | 19 | 0.2% |
| CRE_R | 20 | 0.9% | -0.51 | 14 | 0.2% |
| LAL_R | 6 | 0.3% | 0.87 | 11 | 0.1% |
| LAL_L | 4 | 0.2% | -1.00 | 2 | 0.0% |
| MB_ML_R | 5 | 0.2% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns ORN_DL3 | % In | CV |
|---|---|---|---|---|---|
| ORN_DL3 (L) | 36 | 5-HT | 19.4 | 34.1% | 0.3 |
| ORN_DL3 (R) | 42 | 5-HT | 11.0 | 19.3% | 0.4 |
| ALIN5 (R) | 1 | GABA | 2.8 | 4.9% | 0.0 |
| lLN2T_e (L) | 2 | Unk | 2.6 | 4.6% | 0.7 |
| lLN2F_a (R) | 2 | Unk | 2.4 | 4.2% | 0.6 |
| lLN2T_b (R) | 2 | Unk | 2.3 | 4.0% | 0.4 |
| lLN2P_b (L) | 4 | GABA | 1.8 | 3.1% | 0.9 |
| ALIN5 (L) | 1 | GABA | 1.7 | 3.0% | 0.0 |
| lLN2T_b (L) | 1 | Unk | 1.2 | 2.1% | 0.0 |
| v2LN36 (L) | 1 | 5-HT | 1.1 | 1.9% | 0.0 |
| lLN2F_a (L) | 2 | GABA | 1.1 | 1.9% | 0.3 |
| lLN2P_b (R) | 5 | Unk | 1.0 | 1.8% | 1.3 |
| DL3_lPN (L) | 5 | ACh | 1 | 1.8% | 0.5 |
| lLN2T_e (R) | 2 | 5-HT | 0.9 | 1.6% | 0.2 |
| lLN2F_b (R) | 2 | GABA | 0.6 | 1.0% | 0.4 |
| lLN2F_b (L) | 1 | GABA | 0.5 | 0.9% | 0.0 |
| v2LN36 (R) | 1 | 5-HT | 0.5 | 0.8% | 0.0 |
| DL3_lPN (R) | 5 | ACh | 0.5 | 0.8% | 0.1 |
| ORN_DL3 (na) | 1 | Unk | 0.4 | 0.7% | 0.0 |
| lLN1_bc (R) | 6 | Unk | 0.3 | 0.5% | 0.6 |
| lLN2P_a (L) | 2 | Unk | 0.3 | 0.5% | 0.6 |
| ORN_DA1 (R) | 8 | ACh | 0.3 | 0.5% | 0.5 |
| ORN_DA4m (L) | 4 | 5-HT | 0.2 | 0.3% | 0.5 |
| lLN2X03 (L) | 2 | 5-HT | 0.2 | 0.3% | 0.1 |
| lLN1_bc (L) | 5 | Unk | 0.2 | 0.3% | 0.6 |
| ORN_VA1v (L) | 4 | ACh | 0.2 | 0.3% | 0.2 |
| ORN_DA2 (L) | 5 | ACh | 0.2 | 0.3% | 0.3 |
| ORN_DL4 (L) | 5 | 5-HT | 0.2 | 0.3% | 0.3 |
| lLN2X10 (R) | 2 | ACh | 0.2 | 0.3% | 0.7 |
| CB1132 (R) | 1 | GABA | 0.1 | 0.2% | 0.0 |
| lLN2X10 (L) | 2 | ACh | 0.1 | 0.2% | 0.5 |
| lLN2X12 (R) | 2 | Unk | 0.1 | 0.2% | 0.5 |
| ORN_DL4 (R) | 4 | 5-HT | 0.1 | 0.2% | 0.0 |
| lLN2T_c (R) | 1 | 5-HT | 0.1 | 0.2% | 0.0 |
| ORN_VA1d (L) | 3 | ACh | 0.1 | 0.1% | 0.0 |
| ORN_DL5 (L) | 3 | ACh | 0.1 | 0.1% | 0.0 |
| ORN_DC3 (L) | 2 | ACh | 0.1 | 0.1% | 0.3 |
| lLN2T_c (L) | 1 | 5-HT | 0.1 | 0.1% | 0.0 |
| ORN_DA2 (R) | 3 | ACh | 0.1 | 0.1% | 0.0 |
| ORN_DA3 (L) | 1 | Unk | 0.1 | 0.1% | 0.0 |
| lLN2X11 (R) | 1 | 5-HT | 0.1 | 0.1% | 0.0 |
| ORN_VA6 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| ORN_DL5 (R) | 2 | ACh | 0.1 | 0.1% | 0.0 |
| ORN_VA1v (R) | 2 | Unk | 0.1 | 0.1% | 0.0 |
| lLN2X09 (R) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| ORN_DA1 (L) | 2 | ACh | 0.1 | 0.1% | 0.0 |
| ORN_D (L) | 2 | ACh | 0.1 | 0.1% | 0.0 |
| lLN2X04 (L) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| lLN2X12 (L) | 1 | Unk | 0.0 | 0.0% | 0.0 |
| ORN_DL2v (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| ORN_D (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| ORN_DA4m (R) | 1 | 5-HT | 0.0 | 0.0% | 0.0 |
| ORN_DA4l (L) | 1 | Unk | 0.0 | 0.0% | 0.0 |
| ER4d (R) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| ORN_DA4l (R) | 1 | 5-HT | 0.0 | 0.0% | 0.0 |
| CB2845 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| lLN2P_c (L) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| ORN_DM3 (L) | 1 | 5-HT | 0.0 | 0.0% | 0.0 |
| lLN2X03 (R) | 1 | 5-HT | 0.0 | 0.0% | 0.0 |
| D_adPN (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| ORN_DA3 (R) | 1 | Unk | 0.0 | 0.0% | 0.0 |
| lLN2P_a (R) | 1 | Unk | 0.0 | 0.0% | 0.0 |
| ALIN7 (L) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| CB3679 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| CB2471 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| il3LN6 (L) | 1 | Unk | 0.0 | 0.0% | 0.0 |
| lLN2X04 (R) | 1 | Unk | 0.0 | 0.0% | 0.0 |
| lLN2P_c (R) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| CB1686 (R) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| Li33 (L) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| il3LN6 (R) | 1 | Unk | 0.0 | 0.0% | 0.0 |
| downstream partner | # | NT | conns ORN_DL3 | % Out | CV |
|---|---|---|---|---|---|
| DL3_lPN (L) | 5 | ACh | 37.7 | 26.5% | 0.3 |
| DL3_lPN (R) | 5 | ACh | 24.0 | 16.8% | 0.3 |
| ORN_DL3 (L) | 36 | 5-HT | 19.4 | 13.6% | 0.3 |
| v2LN36 (L) | 1 | 5-HT | 11.2 | 7.9% | 0.0 |
| ORN_DL3 (R) | 42 | 5-HT | 10.0 | 7.0% | 0.5 |
| lLN2P_a (L) | 2 | Unk | 4.1 | 2.9% | 0.5 |
| lLN2P_b (R) | 5 | Unk | 4.1 | 2.8% | 1.6 |
| lLN2T_b (R) | 2 | Unk | 3.7 | 2.6% | 0.6 |
| lLN2F_a (R) | 2 | Unk | 3.1 | 2.1% | 0.7 |
| v2LN36 (R) | 1 | 5-HT | 3.0 | 2.1% | 0.0 |
| lLN2P_b (L) | 4 | GABA | 2.4 | 1.7% | 1.0 |
| lLN2P_a (R) | 3 | Unk | 2.2 | 1.5% | 1.3 |
| lLN2T_b (L) | 1 | Unk | 1.5 | 1.0% | 0.0 |
| v2LN30 (R) | 1 | Unk | 1.2 | 0.8% | 0.0 |
| DA2_lPN (R) | 6 | ACh | 0.9 | 0.6% | 0.6 |
| ALIN7 (L) | 1 | GABA | 0.9 | 0.6% | 0.0 |
| lLN2X10 (R) | 2 | ACh | 0.8 | 0.5% | 0.1 |
| lLN2F_b (R) | 2 | GABA | 0.7 | 0.5% | 0.4 |
| lLN2T_e (L) | 2 | Unk | 0.7 | 0.5% | 0.8 |
| lLN2T_e (R) | 2 | 5-HT | 0.7 | 0.5% | 0.2 |
| lLN2F_a (L) | 2 | GABA | 0.7 | 0.5% | 0.5 |
| lLN2T_c (R) | 1 | 5-HT | 0.7 | 0.5% | 0.0 |
| ALIN7 (R) | 1 | GABA | 0.6 | 0.4% | 0.0 |
| v2LN30 (L) | 1 | Unk | 0.6 | 0.4% | 0.0 |
| lLN2X03 (R) | 3 | 5-HT | 0.5 | 0.4% | 0.5 |
| ORN_DL4 (L) | 10 | 5-HT | 0.5 | 0.4% | 0.5 |
| lLN2T_c (L) | 1 | 5-HT | 0.5 | 0.3% | 0.0 |
| CB2845 (L) | 2 | ACh | 0.4 | 0.3% | 0.6 |
| lLN2X03 (L) | 2 | 5-HT | 0.4 | 0.3% | 0.1 |
| lLN2P_c (R) | 2 | GABA | 0.3 | 0.2% | 0.8 |
| ORN_DL3 (na) | 1 | Unk | 0.3 | 0.2% | 0.0 |
| ORN_DL4 (R) | 9 | 5-HT | 0.3 | 0.2% | 0.3 |
| CB2845 (R) | 2 | ACh | 0.2 | 0.2% | 0.6 |
| lLN2X04 (L) | 2 | GABA | 0.2 | 0.2% | 0.3 |
| ORN_DA1 (L) | 7 | ACh | 0.2 | 0.2% | 0.4 |
| lLN2X11 (R) | 2 | 5-HT | 0.2 | 0.2% | 0.2 |
| DA4l_adPN (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| lLN2X12 (R) | 4 | ACh | 0.2 | 0.1% | 0.5 |
| ORN_DA1 (R) | 6 | ACh | 0.2 | 0.1% | 0.3 |
| il3LN6 (R) | 1 | Unk | 0.2 | 0.1% | 0.0 |
| ORN_VA1d (L) | 4 | Unk | 0.2 | 0.1% | 0.6 |
| ORN_DL5 (R) | 6 | ACh | 0.2 | 0.1% | 0.0 |
| lLN2F_b (L) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| lLN1_bc (R) | 2 | Unk | 0.1 | 0.1% | 0.2 |
| lLN2P_c (L) | 1 | GABA | 0.1 | 0.1% | 0.0 |
| lLN2X04 (R) | 2 | Unk | 0.1 | 0.1% | 0.6 |
| ORN_DL5 (L) | 4 | ACh | 0.1 | 0.1% | 0.3 |
| il3LN6 (L) | 1 | Unk | 0.1 | 0.1% | 0.0 |
| lLN1_bc (L) | 2 | Unk | 0.1 | 0.1% | 0.5 |
| ORN_DA3 (L) | 3 | Unk | 0.1 | 0.1% | 0.4 |
| M_vPNml50 (R) | 1 | GABA | 0.1 | 0.1% | 0.0 |
| lLN2X09 (R) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| ORN_DA2 (R) | 3 | ACh | 0.1 | 0.1% | 0.0 |
| ALIN4 (R) | 1 | GABA | 0.1 | 0.1% | 0.0 |
| ORN_D (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| ALIN5 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| CB1686 (R) | 1 | Unk | 0.1 | 0.0% | 0.0 |
| CB3679 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| CB1676 (R) | 2 | Unk | 0.1 | 0.0% | 0.0 |
| ORN_DC3 (L) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| ORN_DA4m (R) | 2 | Unk | 0.1 | 0.0% | 0.0 |
| ORN_VA6 (L) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| ORN_VA1v (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| ALIN4 (L) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| ORN_VA1v (R) | 1 | Unk | 0.0 | 0.0% | 0.0 |
| ORN_VA1d (R) | 1 | Unk | 0.0 | 0.0% | 0.0 |
| ORN_DC1 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| M_vPNml55 (L) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| DA4m_adPN (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| ORN_DA3 (R) | 1 | Unk | 0.0 | 0.0% | 0.0 |
| ORN_DC4 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| MBON31 (L) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| M_lvPNm25 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| CL210_a (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| CL210 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| lLN2X10 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| DNg34 (R) | 1 | OA | 0.0 | 0.0% | 0.0 |
| CB2471 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| CSD (R) | 1 | 5-HT | 0.0 | 0.0% | 0.0 |
| ORN_DM3 (R) | 1 | 5-HT | 0.0 | 0.0% | 0.0 |
| lLN2X05 (R) | 1 | 5-HT | 0.0 | 0.0% | 0.0 |
| LAL120b (R) | 1 | Glu | 0.0 | 0.0% | 0.0 |
| CB3202 (R) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| DL4_adPN (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| ALIN5 (R) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| CB1141,CB1285 (L) | 1 | GABA | 0.0 | 0.0% | 0.0 |